跳至主要内容
临床试验/NL-OMON31295
NL-OMON31295撤回3 期

The effectiveness of intensive treatment on sympathetic hyperactivity. A randomized, cross-over trial in patients with chronic kidney disease and hypertension - The effect of intensive treatment on sympathetic hyperactivity

niversitair Medisch Centrum Utrecht0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
撤回
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with stable chronic kidney disease and hypertension: i.e. using antihypertensive drugs and/or blood pressure >145/90mmHg when off medication.

排除标准

  • Patients with diabetes mellitus and patients on renal replacement therapy are excluded. In addition, patients with severe liver insufficiency, biliary cirrhosis and cholestasis, pregnant patients and patients in lactation are excluded as Valsartan is contra-indicated for these patients.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验